Ambys Medicines and Takeda Announce Partnership to Pioneer First-in-Class Therapies for the Treatment of Serious Liver Diseases

Ambys Medicines Launches with $140 Million to Pioneer Regenerative Medicine Therapies for Serious Liver Diseases

CytomX Therapeutics Announces Second Quarter 2018 Financial Results

Kala Pharmaceuticals to Present at the Wedbush PacGrow Healthcare Conference

Magenta Therapeutics to Present at Wedbush PacGrow Healthcare Conference